Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$4.75B |
| 2 |
Walmart Inc
WMT
|
+$3.98B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.42B |
| 4 |
Broadcom
AVGO
|
+$943M |
| 5 |
iShares Bitcoin Trust
IBIT
|
+$785M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$572M |
| 2 |
NVIDIA
NVDA
|
+$566M |
| 3 |
Apple
AAPL
|
+$554M |
| 4 |
AbbVie
ABBV
|
+$455M |
| 5 |
Bank of America
BAC
|
+$411M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 51.24% |
| 2 | Technology | 9.52% |
| 3 | Healthcare | 7.46% |
| 4 | Financials | 6.74% |
| 5 | Industrials | 6.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4751
PUT
ATI
ATI
$29.2B
| $562K | ﹤0.01% |
+4,900
| New | +$478K |
|
4752
CALL
Harmony Biosciences
HRMY
$2.32B
| $561K | ﹤0.01% |
+15,000
| New | +$493K |
|
4753
Amylyx Pharmaceuticals
AMLX
$4.14B
| $561K | ﹤0.01% |
46,455
-371,316
| -89% | -$5.04M |
|
4754
Saic
SAIC
$5.45B
| $561K | ﹤0.01% |
5,569
-29,226
| -84% | -$2.79M |
|
|
TOYO
4755
TOYO Co
TOYO
$192M
| $560K | ﹤0.01% |
95,578
-77,367
| -45% | -$521K |
|
|
LNKB
4756
DELISTED
LINKBANCORP
LNKB
| $560K | ﹤0.01% |
67,798
+37,083
| +121% | +$279K |
|
4757
Senseonics Holdings Inc
SENS
$497M
| $559K | ﹤0.01% |
101,288
+88,514
| +693% | +$616K |
|
4758
CALL
Yum China
YUMC
$15.3B
| $559K | ﹤0.01% |
11,700
-600
| -5% | -$27.5K |
|
4759
PUT
HF Sinclair
DINO
$17.2B
| $558K | ﹤0.01% |
12,100
-7,900
| -40% | -$407K |
|
4760
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.9B
| $556K | ﹤0.01% |
10,680
+3,528
| +49% | +$182K |
|
4761
CALL
McEwen Inc
MUX
$1.33B
| $555K | ﹤0.01% |
30,000
-600
| -2% | -$11.2K |
|
4762
Minerva Neurosciences
NERV
$245M
| $554K | ﹤0.01% |
+137,911
| New | +$512K |
|
4763
iShares MSCI ACWI ETF
ACWI
$33.4B
| $553K | ﹤0.01% |
+3,909
| New | +$549K |
|
4764
International General Insurance
IGIC
$1.14B
| $550K | ﹤0.01% |
21,938
+12,746
| +139% | +$299K |
|
4765
Invesco S&P 500 Low Volatility ETF
SPLV
$7.03B
| $550K | ﹤0.01% |
7,694
-24,812
| -76% | -$1.78M |
|
4766
HDFC Bank
HDB
$115B
| $549K | ﹤0.01% |
15,014
-2,356,675
| -99% | -$84.8M |
|
4767
Electromed
ELMD
$252M
| $549K | ﹤0.01% |
18,836
-54,674
| -74% | -$1.43M |
|
|
CCEC
4768
Capital Clean Energy Carriers
CCEC
$1.37B
| $547K | ﹤0.01% |
26,543
+651
| +3% | +$13.7K |
|
4769
Cardiff Oncology
CRDF
$76.7M
| $546K | ﹤0.01% |
194,420
+158,519
| +442% | +$368K |
|
|
CEPO
4770
Cantor Equity Partners I
CEPO
$274M
| $546K | ﹤0.01% |
52,449
-63,472
| -55% | -$664K |
|
4771
PUT
Restaurant Brands International
QSR
$27.2B
| $546K | ﹤0.01% |
8,000
+4,200
| +111% | +$289K |
|
4772
PUT
Lamb Weston
LW
$7.53B
| $545K | ﹤0.01% |
13,000
-94,700
| -88% | -$5.57M |
|
4773
PUT
Agios Pharmaceuticals
AGIO
$2.05B
| $544K | ﹤0.01% |
+20,000
| New | +$702K |
|
4774
OP Bancorp
OPBK
$227M
| $544K | ﹤0.01% |
38,537
-6,046
| -14% | -$82.7K |
|
|
AVB
4775
CALL
DELISTED
AvalonBay Communities
AVB
| $544K | ﹤0.01% |
3,000
-6,200
| -67% | -$1.13M |
|
Similar funds
Israel Englander's Q4 2025 Portfolio in Review
As of Q4 2025, Israel Englander held 6,645 positions worth $238B, up 1.5% from $234B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Israel Englander's Q4 2025 filing shows 668 new, 2,203 increased, 2,701 reduced and 696 closed positions. Its largest new stake was iShares Russell 1000 ETF: 455,129 shares worth $170M. The largest sale was Microsoft, an estimated $572M.
By sector, the portfolio is most concentrated in Miscellaneous at 51% of assets, down from 53% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q4 2025 buy was iShares Russell 1000 ETF: 455,129 shares worth $170M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $4.75B increase.
- Israel Englander's biggest Q4 2025 reduction was Microsoft, cutting an estimated $572M.
- Israel Englander fully exited Mr. Cooper in Q4 2025, selling an estimated $277M.
- Israel Englander's ten largest holdings make up 19% of its $238B portfolio in Q4 2025.
- Israel Englander opened 668 new positions and closed 696 in Q4 2025.
- Israel Englander's portfolio value rose 1.5% quarter-over-quarter to $238B.
Based on Millennium Management's 13F filing for Q4 2025, filed 17 Feb 2026.